Cigna (CI) fundamentals: P/E, valuation, undervalued?
Cigna · Health Care · ref. ETF XLV · price $277.67
In short — Cigna trades at 11.5× earnings (P/E), 8.3× forward, with a net margin of 2.3 % and revenue growth of +7 %. Read: Cheap for the growth (P/E 8 for ~10% growth (PEG 0.8)).
Is Cigna stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$277.67-7.1% over range
Aug 28, 25low $244.41 · high $311Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
69% recommend buying · 13 analysts
Valuation : Cheap for the growth — P/E 8 for ~10% growth (PEG 0.8)
Valuation
11.5
P/E (price/earnings)
8.3
Forward P/E
1.13
PEG
1.7
Price/book (P/B)
$73.4B
Market cap
24.18
EPS
Profitability & growth
2.3 %
Net margin
+7 %
Revenue growth
+10 %
Earnings growth
$31.9B
Total debt
Cigna income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $180.6B | $6.7B | 3.7 % |
| 2023 | $195.3B | $5.2B | 2.6 % |
| 2024 | $247.1B | $3.4B | 1.4 % |
| 2025 | $274.9B | $6.0B | 2.2 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Cigna's P/E and is the stock undervalued? What's a good P/E?
Cigna's P/E is 11.5 (forward 8.3). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is Cigna profitable?
Cigna has a net margin of 2.3 % (EPS 24.18). The company is profitable.
Is CI stock expensive?
Our read: "Cheap for the growth" — P/E 8 for ~10% growth (PEG 0.8). Cross-check with growth and sector.
💬 A question about Cigna? The JPI assistant answers using our backtest data.